Cargando…

The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma

RNA modification of m6A/m5C/m1A contributes to the occurrence and development of cancer. Consequently, this study aimed to investigate the functions of m6A/m5C/m1A regulated genes in the prognosis and immune microenvironment of hepatocellular carcinoma (HCC). The expression levels of 45 m6A/m5C/m1A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Dan, Li, Kai, Zhang, Wei, Yang, Kong-Wu, Mu, De-An, Jiang, Guo-Jun, Shi, Rong-Shu, Ke, Di
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272990/ https://www.ncbi.nlm.nih.gov/pubmed/35833147 http://dx.doi.org/10.3389/fimmu.2022.918140

Ejemplares similares

The m(6)A-related gene signature stratifies poor prognosis patients and characterizes immunosuppressive microenvironment in hepatocellular carcinoma
por: Ma, Ensi, et al.
Publicado: (2023)

A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
por: Wang, Xuewen, et al.
Publicado: (2022)

Implications of m6A-associated snRNAs in the prognosis and immunotherapeutic responses of hepatocellular carcinoma
por: Zhang, Cheng, et al.
Publicado: (2022)

Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma
por: Xie, Hongjun, et al.
Publicado: (2022)

A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma
por: Zhao, Mingxing, et al.
Publicado: (2022)

The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)

LRPPRC facilitates tumor progression and immune evasion through upregulation of m(6)A modification of PD-L1 mRNA in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

Comprehensive analysis of m(6)A/m(5)C/m(1)A-related gene expression, immune infiltration, and sensitivity of antineoplastic drugs in glioma
por: Zhao, Kai, et al.
Publicado: (2022)

Construction of an m6A- and neutrophil extracellular traps-related lncRNA model to predict hepatocellular carcinoma prognosis and immune landscape
por: Zhan, Tian, et al.
Publicado: (2023)

Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma
por: Jin, Yi, et al.
Publicado: (2021)

Effect of the m6ARNA gene on the prognosis of thyroid cancer, immune infiltration, and promising immunotherapy
por: Xia, Minqi, et al.
Publicado: (2022)

The m(6)A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients
por: Meng, Zibo, et al.
Publicado: (2020)

A Starvation-Based 9-mRNA Signature Correlates With Prognosis in Patients With Hepatocellular Carcinoma
por: Lei, Dengliang, et al.
Publicado: (2021)

Identification of m6A modification patterns and development of m6A–hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer
por: Shen, Xi, et al.
Publicado: (2022)

Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma
por: Peng, Yue-Ling, et al.
Publicado: (2023)

Cross-Talk Between m(6)A- and m(5)C-Related lncRNAs to Construct a Novel Signature and Predict the Immune Landscape of Colorectal Cancer Patients
por: Song, Wei, et al.
Publicado: (2022)

Identification of three m6A‐related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma
por: Li, Zedong, et al.
Publicado: (2020)

Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma
por: Xu, Ziwu, et al.
Publicado: (2023)

m6A-related metabolism molecular classification with distinct prognosis and immunotherapy response in soft tissue sarcoma
por: Huang, Zhen-Dong, et al.
Publicado: (2022)

An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma
por: Shao, Dongqi, et al.
Publicado: (2022)

M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma
por: Qu, Xiaodong, et al.
Publicado: (2022)

Developing an m5C regulator–mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer
por: Zhang, Rixin, et al.
Publicado: (2023)

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)

Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma
por: Xu, Yan, et al.
Publicado: (2022)

Elevated MPP6 expression correlates with an unfavorable prognosis, angiogenesis and immune evasion in hepatocellular carcinoma
por: Cheng, Qianqian, et al.
Publicado: (2023)

m6A modifications regulate intestinal immunity and rotavirus infection
por: Wang, Anmin, et al.
Publicado: (2022)

Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
por: Wang, Nan, et al.
Publicado: (2014)

m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment
por: Zhang, Tingting, et al.
Publicado: (2022)

Prognostic signature and immune efficacy of m(1)A‐, m(5)C‐ and m(6)A‐related regulators in cutaneous melanoma
por: Wu, Xian rui, et al.
Publicado: (2021)

M2 macrophage-related gene signature in chronic rhinosinusitis with nasal polyps
por: Zhu, Ying, et al.
Publicado: (2022)

Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response
por: Jiang, Hongye, et al.
Publicado: (2021)

Prognosis Analysis and Validation of m(6)A Signature and Tumor Immune Microenvironment in Glioma
por: Lin, Shaojian, et al.
Publicado: (2020)

Diagnostic gene signatures and aberrant pathway activation based on m6A methylation regulators in rheumatoid arthritis
por: Geng, Qishun, et al.
Publicado: (2022)

Construction of m6A-based prognosis signature and prediction for immune and anti-angiogenic response
por: Wang, Xiang-Xu, et al.
Publicado: (2022)

m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma
por: Zou, Yan, et al.
Publicado: (2022)

The regulation of antiviral innate immunity through non-m(6)A RNA modifications
por: Shen, Shenghai, et al.
Publicado: (2023)

Integrative Analysis of Small RNA and mRNA Expression Profiles Identifies Signatures Associated With Chronic Epididymitis
por: Gong, Jialei, et al.
Publicado: (2022)

Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma
por: Xiao, Yu, et al.
Publicado: (2023)

Non-Invasive Diagnosis for Acute Rejection Using Urinary mRNA Signature Reflecting Allograft Status in Kidney Transplantation
por: Seo, Jung-Woo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2pvqg1h0raav5bk072cpimlng7